Description
VITRAKVI 100MG CAPSULES
First action · last action
2019-10-18 · 2019-10-25
Transactions
2
First transaction's obligation
$96,432
Base + all options value (sum of deltas)
$73,913
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2019-10-18+$96,432= $96,432
- Mod P000012019-10-25-$22,519= $73,913
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2019-10-18 | +$96,432 | $96,432 | VITRAKVI 100MG CAPSULES |
| Mod P00001· FUNDING ONLY ACTION | 2019-10-25 | −$22,519 | $73,913 | VITRAKVI 100MG CAPSULES |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI HJ39FBLVE7L5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25026P0991 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $43,680 | FY2026 |
| 36C26226P1412 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $38,220 | FY2026 |
| 36C24826P1108 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $54,600 | FY2026 |
| 36C24226P0845 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $46,019 | FY2026 |
| 36C24926P0361 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $36,814 | FY2026 |
| 36C24226P0588 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $46,019 | FY2026 |
Other recipients under 6505 from 258-NETWORK CNTRCT OFF 22G (36C258) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25821P0342 | MCKESSON CORPORATION | 258-NETWORK CNTRCT OFF 22G (36C258) | $750 | FY2021 |
| 36C25821N0393 | UNIVERSITY OF NEW MEXICO | 258-NETWORK CNTRCT OFF 22G (36C258) | $31,866 | FY2021 |
| 36C25821P0312 | LANTHEUS MEDICAL IMAGING, INC. | 258-NETWORK CNTRCT OFF 22G (36C258) | $101,384 | FY2021 |
| 36C25821N0382 | CSL BEHRING L.L.C. | 258-NETWORK CNTRCT OFF 22G (36C258) | $152,276 | FY2021 |
| 36C25821N0375 | CARDINAL HEALTH 414, LLC | 258-NETWORK CNTRCT OFF 22G (36C258) | $182,654 | FY2021 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25820P0029_3600_-NONE-_-NONE- · retrieved 2026-09-26.